Colorectal Cancer: Janine's Patient Story
This colorectal cancer diagnosis at a glance
- Sex
- Female
- Treatment
- chemotherapy, radiation and surgery
Treatment course, step by step
- She received 4.5 months of FOLFOX chemotherapy.
- She then received 30 days of additional chemotherapy with daily radiation.
- She underwent tumor-resection surgery with a temporary ileostomy.
- Her ileostomy was reversed on December 5, 2024.
What happened, in summary
Janine Stellacci had been an athlete since her teenage years. Around age 40, she began experiencing severe fatigue and changing gastrointestinal symptoms, which she initially attributed to stress, hormones, and being a woman. After several years, occasional blood in the bathroom became a daily occurrence. A gastroenterologist quickly arranged a colonoscopy, and the tumor was identified on January 2, 2024.
Janine spent most of 2024 in treatment. She first received 4.5 months of FOLFOX chemotherapy. That was followed by 30 days of another chemotherapy given alongside daily radiation. She then underwent surgery to remove the tumor and received a temporary ileostomy. The ileostomy was reversed on December 5, 2024.
Throughout treatment and recovery, Janine tried to maintain an exercise routine as much as her health allowed. Her experience reinforced how important she believes early screening can be, particularly when symptoms such as rectal bleeding persist. Looking back, she felt that waiting longer could have had serious consequences. Janine now uses her story to encourage people to pursue timely screening and to support making colorectal cancer screening both accessible and affordable.
Where this story comes from
This is a lay summary of an account first published by Fight Colorectal Cancer. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer